- RSVpreF vaccination in pregnancy: a meta-analysis of maternal-fetal safety and infant efficacy
-
Marchand GJ, Massoud AT, Abdelsattar AT, McCullough PA
- KMID: 2561014
- Obstet Gynecol Sci.
- 2024 Nov;67(6):511-524.
- doi: 10.5468/ogs.24213
In May 2023, the United States Food and Drug Administration approved a Pfizer©-sponsored (Pfizer, New York, NY, USA) bivalent respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) RSV vaccine (AbrysvoTM... -
- CITED
-
- Close
- SHARE
-
- Close
